Polio Vaccines Market

Polio vaccines are vaccines used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 22 in 2021.

Scope of the Report:

Polio Vaccines Market focuses on the Polio Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. Polio Vaccines Market categorizes the market based on manufacturers, regions, type and application.

The prevalence of Polio disease is key driver to lead to growth of polio vaccines market. mainly affects children under 5 years of age. Up to 70% of all the infections in children are without any symptoms and about 25-30% of infections in children causes? nonspecific illness without clinical or laboratory evidence of central nervous system invasion. This has created a gesture for the organizations to focus on the vaccines options for making prophylactic approach towards the prevention of the disorder, which in turn is expected to fuel the polio vaccines market in the near future. As far as the geography is concerned, North American is currently leading the market, the reason being initiatives laid down by the government for encouraging the adoption of immunization against diseases like influenza and HPV.

The worldwide market for Polio Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2027, from xx million US$ in 2021,

Market Segment by Manufacturers, Polio Vaccines Market covers

CSL

GlaxoSmithKline

Johnson & Johnson

MedImmune

Merck

Pfizer

Sanofi Pasteur

Serum Institute

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

IPV

OPV

Market Segment by Applications, can be divided into

Age (0-1)

Age Above 1

There are 15 Chapters to deeply display the global Polio Vaccines market.

Chapter 1, to describe Polio Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Polio Vaccines, with sales, revenue, and price of Polio Vaccines, in 2016 and 2021;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2021;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Polio Vaccines, for each region, from 2027 to 2022;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2027 to 2022;

Chapter 12, Polio Vaccines market forecast, by regions, type and application, with sales and revenue, from 2022 to 2027;

Chapter 13, 14 and 15, to describe Polio Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source